Solid Tumor
Showing NaN - NaN of 94
Bone Cancer, Bone Tumor, Solid Tumor Trial in United States (153-Sm-DOTMP (Samarium-153-DOTMP))
Recruiting
- Bone Cancer
- +4 more
- 153-Sm-DOTMP (Samarium-153-DOTMP)
-
Chicago, Illinois
- +3 more
Aug 18, 2023
Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +15 more
- A2B530
- xT-Onco with HLA-LOH Assay
-
Duarte, California
- +6 more
Feb 10, 2023
Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)
Recruiting
- Non-Small Cell Lung Cancer
- +4 more
- GRT-C903
- +3 more
-
Phoenix, Arizona
- +13 more
Jan 30, 2023
Solid Tumor Trial in United Kingdom, United States (Farletuzumab ecteribulin)
Recruiting
- Solid Tumor
- Farletuzumab ecteribulin
-
Tucson, Arizona
- +26 more
Jan 30, 2023
Solid Tumor, Lymphoma Trial in Israel, United States (MK-2118 (IT), MK-2118 (SC), Pembrolizumab)
Completed
- Solid Tumor
- Lymphoma
- MK-2118 (IT)
- +2 more
-
La Jolla, California
- +7 more
Jan 23, 2023
Solid Tumor Trial in Houston (Single Injection of IVS-3001- Anti - HLA-G CAR-T cells, Fludarabine phosphate, Cyclophosphamide)
Not yet recruiting
- Solid Tumor
- Single Injection of IVS-3001- Anti - HLA-G CAR-T cells
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jan 19, 2023
Solid Tumor, Non Small Cell Lung Cancer, Pancreatic Cancer Trial in Israel, United States (CM-24 and Nivolumab - Dose
Recruiting
- Solid Tumor
- +6 more
- CM-24 and Nivolumab - Dose Escalation
- +4 more
-
Scottsdale, Arizona
- +10 more
Jan 17, 2023
Liver Cell Carcinoma Trial in Houston (CATCH T cells, Cytoxan, Fludara)
Recruiting
- Liver Cell Carcinoma
- +7 more
- CATCH T cells
- +2 more
-
Houston, TexasHouston Methodist Hospital
Dec 19, 2022
Tumors, Metastatic Cancer, Advanced Cancer Trial in United States (Niraparib, TSR-042, Carboplatin-Paclitaxel)
Solid Tumor, B-Raf Mutation-Related Tumors Trial in Australia, United States (BGB-3245)
Recruiting
- Solid Tumor
- B-Raf Mutation-Related Tumors
-
Boston, Massachusetts
- +4 more
Oct 25, 2022
Solid Tumor, Urethral Cancer Trial in Houston (Bortezomib, Gemcitabine, Doxorubicin)
Active, not recruiting
- Solid Tumor
- Urethral Cancer
- Bortezomib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 22, 2022
Metastatic Cancer, Solid Tumor Trial in Worldwide (Sym021, Sym022, Sym023)
Active, not recruiting
- Metastatic Cancer
- Solid Tumor
- Sym021
- +3 more
-
Aurora, Colorado
- +17 more
Sep 8, 2022